These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22047059)

  • 1. Cognitive effects of chemotherapy-induced menopause in breast cancer.
    Vearncombe KJ; Rolfe M; Andrew B; Pachana NA; Wright M; Beadle G
    Clin Neuropsychol; 2011 Nov; 25(8):1295-313. PubMed ID: 22047059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
    Hermelink K; Henschel V; Untch M; Bauerfeind I; Lux MP; Munzel K
    Cancer; 2008 Nov; 113(9):2431-9. PubMed ID: 18823033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.
    Tager FA; McKinley PS; Schnabel FR; El-Tamer M; Cheung YK; Fang Y; Golden CR; Frosch ME; Habif U; Mulligan MM; Chen IS; Hershman DL
    Breast Cancer Res Treat; 2010 Aug; 123(1):25-34. PubMed ID: 19894112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
    Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
    Quesnel C; Savard J; Ivers H
    Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study.
    Hermelink K; Untch M; Lux MP; Kreienberg R; Beck T; Bauerfeind I; Münzel K
    Cancer; 2007 May; 109(9):1905-13. PubMed ID: 17351951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
    Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
    J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of cognitive decline after chemotherapy in breast cancer patients.
    Vearncombe KJ; Rolfe M; Wright M; Pachana NA; Andrew B; Beadle G
    J Int Neuropsychol Soc; 2009 Nov; 15(6):951-62. PubMed ID: 19709455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
    Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
    Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
    Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF
    J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is cognitive functioning detrimentally affected after early, induced menopause?
    Vearncombe KJ; Pachana NA
    Menopause; 2009; 16(1):188-98. PubMed ID: 18724262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Chemobrain' in breast carcinoma?: a prologue.
    Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
    Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
    Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
    Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
    Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
    Psychooncology; 2009 Feb; 18(2):134-43. PubMed ID: 18551510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy.
    Collins B; Mackenzie J; Tasca GA; Scherling C; Smith A
    J Int Neuropsychol Soc; 2014 Apr; 20(4):370-9. PubMed ID: 24229809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.
    Shilling V; Jenkins V; Morris R; Deutsch G; Bloomfield D
    Breast; 2005 Apr; 14(2):142-50. PubMed ID: 15767184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
    Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
    J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.
    Schultz PN; Klein MJ; Beck ML; Stava C; Sellin RV
    J Clin Nurs; 2005 Feb; 14(2):204-11. PubMed ID: 15669929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
    Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
    J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
    Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A
    Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.